CA2347110C - A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid - Google Patents

A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid Download PDF

Info

Publication number
CA2347110C
CA2347110C CA002347110A CA2347110A CA2347110C CA 2347110 C CA2347110 C CA 2347110C CA 002347110 A CA002347110 A CA 002347110A CA 2347110 A CA2347110 A CA 2347110A CA 2347110 C CA2347110 C CA 2347110C
Authority
CA
Canada
Prior art keywords
radiotherapy
bladder
cancer
week
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002347110A
Other languages
English (en)
French (fr)
Other versions
CA2347110A1 (en
Inventor
Peter J. Pommerville
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mylan Teoranta
Original Assignee
Bioniche Teoranta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Teoranta filed Critical Bioniche Teoranta
Publication of CA2347110A1 publication Critical patent/CA2347110A1/en
Application granted granted Critical
Publication of CA2347110C publication Critical patent/CA2347110C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002347110A 1998-10-22 1999-10-22 A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid Expired - Lifetime CA2347110C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10518498P 1998-10-22 1998-10-22
US60/105,184 1998-10-22
PCT/CA1999/000994 WO2000024387A2 (en) 1998-10-22 1999-10-22 A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid

Publications (2)

Publication Number Publication Date
CA2347110A1 CA2347110A1 (en) 2000-05-04
CA2347110C true CA2347110C (en) 2008-08-26

Family

ID=22304511

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002347110A Expired - Lifetime CA2347110C (en) 1998-10-22 1999-10-22 A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid

Country Status (12)

Country Link
US (2) US6667296B1 (enExample)
EP (1) EP1124546B1 (enExample)
JP (1) JP4685242B2 (enExample)
AT (1) ATE264674T1 (enExample)
AU (1) AU761158B2 (enExample)
CA (1) CA2347110C (enExample)
DE (1) DE69916643T2 (enExample)
DK (1) DK1124546T3 (enExample)
ES (1) ES2219070T3 (enExample)
NZ (1) NZ511068A (enExample)
PT (1) PT1124546E (enExample)
WO (1) WO2000024387A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9906619D0 (en) 1999-03-23 1999-05-19 Zeneca Resins Bv Compositions
US20070173479A1 (en) * 2003-12-10 2007-07-26 Keryx Biopharmaceuticals, Inc. Methods Using Sulodexide for the Treatment of Bladder Disease
JP2007233949A (ja) * 2006-03-03 2007-09-13 Kyoto Univ 排尿管理システム
ITMI20061030A1 (it) 2006-05-26 2007-11-27 Altergon Sa Nuova composizione comprendente glicosamminoglicani a viscosita' controllata e uso di tale composizione nella terapuia della cistite cronica
DE102006060953A1 (de) 2006-12-12 2008-08-07 Farco-Pharma Gmbh Pharmazeutische Zubereitung für die Behandlung entzündlicher Erkrankungen des Urogenitaltraktes
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
EP3960215B1 (en) 2009-12-15 2024-10-16 Incept, LLC Implants and biodegradable fiducial markers
RU2557949C1 (ru) * 2014-08-14 2015-07-27 Общество с ограниченной ответственностью "КОЛЕТЕКС" Способ лечения лучевого и интерстициального цистита
WO2016146573A1 (en) * 2015-03-13 2016-09-22 Repoceuticals Aps Melatonin for preventing and treating radiation cystitis
RU2676431C1 (ru) * 2018-02-26 2018-12-28 Федеральное государственное бюджетное учреждение "Российский научный центр радиологии и хирургических технологий имени академика А.М. Гранова" Министерства здравоохранения Российской Федерации (ФГБУ "РНЦРХТ им. ак. А.М. Гранова" Минздрава России) Способ моделирования лучевого цистита
WO2019236453A1 (en) * 2018-06-03 2019-12-12 Glycomira Therapeutics, Inc. Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and /or chemotherapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN181358B (enExample) * 1995-02-14 1998-05-30 Bioniche Inc
US5880108A (en) * 1995-02-14 1999-03-09 Bioniche, Inc. Method for treating the internal urinary bladder and associated structures using hyaluronic acid
CA2154103C (en) 1995-07-18 1998-02-24 Samuel Simon Asculai Treatment of mucous membrane disease, trauma or condition and for the relief of pain
WO1998029125A1 (fr) * 1996-12-27 1998-07-09 Seikagaku Corporation Remedes contre des troubles de la vessie

Also Published As

Publication number Publication date
JP2002528410A (ja) 2002-09-03
EP1124546A2 (en) 2001-08-22
DE69916643D1 (de) 2004-05-27
AU6455899A (en) 2000-05-15
NZ511068A (en) 2003-10-31
WO2000024387A3 (en) 2000-08-03
US20040152662A1 (en) 2004-08-05
WO2000024387A2 (en) 2000-05-04
PT1124546E (pt) 2004-08-31
ATE264674T1 (de) 2004-05-15
EP1124546B1 (en) 2004-04-21
JP4685242B2 (ja) 2011-05-18
DE69916643T2 (de) 2005-04-28
CA2347110A1 (en) 2000-05-04
US6667296B1 (en) 2003-12-23
DK1124546T3 (da) 2004-08-09
AU761158B2 (en) 2003-05-29
ES2219070T3 (es) 2004-11-16

Similar Documents

Publication Publication Date Title
O'Keefe et al. Recurrent sepsis in home parenteral nutrition patients: an analysis of risk factors
US5888986A (en) Method for treating the urinary bladder and associated structures using hyaluronic acid
US8580766B2 (en) Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
Woodley et al. The treatment of severe staphylococcal infections with vancomycin
CA2347110C (en) A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid
Cox Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria
US5880108A (en) Method for treating the internal urinary bladder and associated structures using hyaluronic acid
Stricker et al. Relative value of antibiotics and catheter care in the prevention of urinary tract infection after transurethral prostatic resection
US6232301B1 (en) Remedies for bladder disorders
Bauer et al. Vesical manifestations of chronicgranulomatous disease in children: Its relation to eosinophilic cystitis
Fair et al. Renal abscess
Gorrea et al. Spontaneous healing of ureterogenital fistulas: selection criteria
Pillay et al. Massive proteinuria associated with vesico-ureteral reflux
Humphreys et al. Acute epididymo-orchitis caused by Pseudomonas aeruginosa and treated with ciprofloxacin
Murdoch et al. Oral ciprofloxacin as prophylaxis for optical urethrotomy
RU2222269C2 (ru) Способ лечения панкреонекроза
Wettlaufer Abacterial cystitis: Treatment with sodium oxychlorosene
US20100210600A1 (en) Methods and Compositions for Treating Urogenital Disorders
Bandler et al. Streptomycin in genito-urinary infections
GREENBERG et al. Methylene Blue in the Treatment of Urinary Tuberculosis
Li et al. Individualised Wound Treatment Strategies for Skin Lesions Caused by Calcium Gluconate Extravasation in Neonates: A Case Report
Al-Khuwaitir et al. Chronic granulomatous disease with recurrent hepatic abscesses in an adult
JP2012116818A (ja) 泌尿器系疾患を治療する医薬組成物
Bouder et al. Eosinophilic Cystitis: Medical and Surgical Management
MXPA97006182A (es) Uso de acido hialuronico para el tratamiento de cistitis intersticial

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20191022